Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

House Pushes FDA To Expedite Sunscreen Ingredient Reviews

This article was originally published in The Tan Sheet

Executive Summary

Reps. Dingell and Whitfield ask for FDA’s assistance on legislation they are writing to expedite the agency’s review of additional sunscreen ingredients. CDER Director Woodcock pledges FDA help, but explains the agency’s OTC ingredient reviews are “backlogged.”

You may also be interested in...



Sunscreen Ingredient Legislation Could Ride Wave Of Momentum

Legislators and stakeholders suggest that the Sunscreen Innovation Act, which calls for an acceleration of FDA’s review of sunscreen active-ingredient time-and-extent applications, will pass this year. The House version of the bill is expected to advance first.

Sunscreen Ingredient Legislation Could Ride Wave Of Momentum

Legislators and stakeholders suggest that the Sunscreen Innovation Act, which calls for an acceleration of FDA’s review of sunscreen active-ingredient time-and-extent applications, will pass this year. The House version of the bill is expected to advance first.

FDA Sunscreen Decision Deadlines, Expedited TEAs Proposed

The Sunscreen Innovation Act, introduced in both the House and the Senate, would streamline the process for FDA review of sunscreen TEAs and impose deadlines for agency action.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

OM017301

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel